HUMAN EPIDIDYMIS PROTEIN 4 IS A NOVEL FIBROSIS MARKER TO PREDICT PATHOLOGICAL CARDIAC REMODELING AND ADVERSE OUTCOMES IN PATIENTS WITH DILATED CARDIOMYOPATHY

被引：3

作者：

Yamamoto, Masahiro ^{[1
]}

Hanatani, Shinsuke ^{[1
]}

Toshifumi, Ishida ^{[1
]}

Satoru, Yamamura ^{[1
]}

Kyoko, Hirakawa ^{[1
]}

Takashio, Seiji ^{[1
]}

Izumiya, Yasuhiro ^{[1
]}

Tsujita, Kenichi ^{[1
]}

机构：

[1] Kumamoto Univ Hosp, Kumamoto, Japan

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期

关键词：

D O I：

10.1016/S0735-1097(18)31304-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A763

引用

页码：763 / 763

页数：1

共 50 条

[31] Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy
Yuki Ikeda
Takayuki Inomata
Teppei Fujita
Yuichiro Iida
Takeru Nabeta
Shunsuke Ishii
Emi Maekawa
Tomoyoshi Yanagisawa
Tomohiro Mizutani
Takashi Naruke
Toshimi Koitabashi
Ichiro Takeuchi
Junya Ako
Heart and Vessels, 2016, 31 : 1817 - 1825
[32] Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy
Ikeda, Yuki
Inomata, Takayuki
Fujita, Teppei
Iida, Yuichiro
Nabeta, Takeru
Ishii, Shunsuke
Maekawa, Emi
Yanagisawa, Tomoyoshi
Mizutani, Tomohiro
Naruke, Takashi
Koitabashi, Toshimi
Takeuchi, Ichiro
Ako, Junya
HEART AND VESSELS, 2016, 31 (11) : 1817 - 1825
[33] Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy
Komamura, K
Sasaki, T
Hanatani, A
Kim, J
Hashimura, K
Ishida, Y
Ohkaru, Y
Asayama, K
Tanaka, T
Ogai, A
Nakatani, T
Kitamura, S
Kangawa, K
Miyatake, K
Kitakaze, M
HEART, 2006, 92 (05) : 615 - 618
[34] Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischemic dilated cardiomyopathy
Komamura, K.
Hanatani, A.
Hashimura, K.
Kato, T.
Mano, A.
Kim, J.
Nakatani, T.
Kitamura, S.
Tomoike, H.
Kitakaze, M.
EUROPEAN HEART JOURNAL, 2007, 28 : 415 - 415
[35] SERUM HUMAN EPIDIDYMIS PROTEIN 4 LEVELS PREDICT CLINICAL WORSENING IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
Jin, Q.
Tang, Y.
Zhao, Z.
Luo, Q.
Liu, Z.
CHEST, 2019, 155 (04) : 290A - 290A
[36] Global longitudinal diastolic strain rate as a novel marker for predicting adverse outcomes in hypertrophic cardiomyopathy by cardiac magnetic resonance tissue tracking
Li, Z-L
He, S.
Xia, C-C
Peng, W-L
Li, L.
Liu, K-L
Zhang, J-G
Pu, J.
Guo, Y-K
CLINICAL RADIOLOGY, 2021, 76 (01) : 78.e19 - 78.e25
[37] Coronary Sinus Neuropeptide Y Levels Predict Adverse Outcomes in Patients With Cardiomyopathy and Conduction Disturbance Undergoing Cardiac Resynchronization Therapy
Ajijola, Olujimi A.
Gonzales, Matthew J.
Chatterjee, Neal A.
Gornbein, Jeffrey
Singh, Jagmeet P.
Herring, Neil
CIRCULATION, 2017, 136
[38] Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation
Hennings, Elisa
Blum, Steffen
Aeschbacher, Stefanie
Coslovsky, Michael
Knecht, Sven
Eken, Ceylan
Lischer, Mirko
Paladini, Rebecca E.
Krisai, Philipp
Reichlin, Tobias
Rodondi, Nicolas
Beer, Juerg H.
Ammann, Peter
Conte, Giulio
De Perna, Maria Luisa
Kobza, Richard
Blum, Manuel R.
Bossard, Matthias
Kastner, Peter
Ziegler, Andre
Mueller, Christian
Bonati, Leo H.
Pfister, Otmar
Zuern, Christine S.
Conen, David
Kuhne, Michael
Osswald, Stefan
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (06):
[39] Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
Escudero, Jose M.
Auge, Jose M.
Filella, Xavier
Torne, Aureli
Pahisa, Jaume
Molina, Rafael
CLINICAL CHEMISTRY, 2011, 57 (11) : 1534 - 1544
[40] Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Uno, Masaya
Matsuo, Rie
Maezawa, Naoki
Kato, Tomoyasu
OBSTETRICS & GYNECOLOGY SCIENCE, 2023, 66 (04) : 290 - 299

← 1 2 3 4 5 →